Assignment of tumor subtype by genomic testing and pathologic-based approximations: implications on patient’s management and therapy selection
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Assignment of tumor subtype by genomic testing and pathologic-based approximations: implications on patient’s management and therapy selection
Authors
Keywords
Breast cancer, Molecular subtypes, PAM-50, Claudin-low
Journal
Clinical & Translational Oncology
Volume 16, Issue 4, Pages 386-394
Publisher
Springer Nature
Online
2013-08-01
DOI
10.1007/s12094-013-1088-z
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Correlation between response to neoadjuvant chemotherapy and survival in locally advanced breast cancer patients
- (2012) A. Romero et al. ANNALS OF ONCOLOGY
- Assessment of Topoisomerase II α Status in Breast Cancer by Quantitative PCR, Gene Expression Microarrays, Immunohistochemistry, and Fluorescence in Situ Hybridization
- (2011) Atocha Romero et al. AMERICAN JOURNAL OF PATHOLOGY
- Strategies for subtypes—dealing with the diversity of breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011
- (2011) A. Goldhirsch et al. ANNALS OF ONCOLOGY
- Genomic predictors of response to doxorubicin versus docetaxel in primary breast cancer
- (2011) M. Martin et al. BREAST CANCER RESEARCH AND TREATMENT
- The prognostic contribution of clinical breast cancer subtype, age, and race among patients with breast cancer brain metastases
- (2010) Carey K. Anders et al. CANCER
- A Comparison of PAM50 Intrinsic Subtyping with Immunohistochemistry and Clinical Prognostic Factors in Tamoxifen-Treated Estrogen Receptor-Positive Breast Cancer
- (2010) T. O. Nielsen et al. CLINICAL CANCER RESEARCH
- The Association Between Biological Subtype and Isolated Regional Nodal Failure After Breast-Conserving Therapy
- (2010) Jennifer Y. Wo et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Breast cancer molecular profiling with single sample predictors: a retrospective analysis
- (2010) Britta Weigelt et al. LANCET ONCOLOGY
- Deconstructing the molecular portraits of breast cancer
- (2010) Aleix Prat et al. Molecular Oncology
- Adjuvant Docetaxel for High-Risk, Node-Negative Breast Cancer
- (2010) Miguel Martín et al. NEW ENGLAND JOURNAL OF MEDICINE
- Subtyping of Breast Cancer by Immunohistochemistry to Investigate a Relationship between Subtype and Short and Long Term Survival: A Collaborative Analysis of Data for 10,159 Cases from 12 Studies
- (2010) Fiona M. Blows et al. PLOS MEDICINE
- Extensive Soft-Tissue Metastases From Malignant Pleural Mesothelioma
- (2009) Tjeerd S. Aukema et al. JOURNAL OF CLINICAL ONCOLOGY
- Breast Cancer Subtypes and Response to Docetaxel in Node-Positive Breast Cancer: Use of an Immunohistochemical Definition in the BCIRG 001 Trial
- (2009) Judith Hugh et al. JOURNAL OF CLINICAL ONCOLOGY
- Supervised Risk Predictor of Breast Cancer Based on Intrinsic Subtypes
- (2009) Joel S. Parker et al. JOURNAL OF CLINICAL ONCOLOGY
- Ki67 Index, HER2 Status, and Prognosis of Patients With Luminal B Breast Cancer
- (2009) Maggie C. U. Cheang et al. JNCI-Journal of the National Cancer Institute
- Basal-Like Breast Cancer Defined by Five Biomarkers Has Superior Prognostic Value than Triple-Negative Phenotype
- (2008) M. C.U. Cheang et al. CLINICAL CANCER RESEARCH
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started